Possibility of Pancoronavirus Vax, Rubella Injection Inventor Says | Pune News

PUNE: Dr. Stanley, the inventor of the rubella vaccine Plotkin It hinted at the possibility of developing a pancoronavirus jab.
“The only way we can deal with the many variants of Covid is to make a pancoronavirus vaccine. Fortunately, the basic research done has shown that it is possible. It’s a crazy idea. Not, “said Dr. Stanley.
Professor Emeritus of Johns Hopkins, America’s first research university, spoke at the Asian Economic Dialogue 2022 on Friday (February 25). world.
“In other words, we can develop vaccines that act against all coronaviruses and prevent them from causing illness in people,” he said.
Explaining the need for such a broad spectrum Covid vaccine, Dr. Protokin “If you look at the distribution of the coronavirus, it’s all over Asia. Not only in China, but also in countries such as Laos, Cambodia, and Myanmar. The bat is a carrier of the coronavirus and can, of course, infect animals and humans. I think we have to look to the future and recognize that the coronavirus will increase. There were SARS-1, MERS, and now SARS-2. By making a pan coronavirus vaccine, the future You need to be prepared. ”
Dr. Protokin called the hesitation of vaccines a “global phenomenon.”
He said. “It’s basically because people aren’t educated. Some people are afraid of injections and afraid of receiving injected substances. They are afraid of what they do to them. We have. All we have to do is face the safety of vaccines, both as a scientific and public relations issue. ”
He also emphasized vaccine safety studies that are closely linked to vaccine development. “Nothing in the world is 100% safe. It’s ridiculous to think it’s possible. On the other hand, we know that vaccines are safe and protective. In addition, the reactions that are triggered. Is almost trivial, and short-term serious reactions are very rare. ”
Dr. Protokin also emphasized the course of statistics in the school curriculum. “The simple point is that if something happens once in 100 times and something happens once in 10,000 times, the risks are clearly different, but many people don’t understand it. Therefore, every child must take a statistics course to learn how to assess risk. This applies not only to vaccines, but to other aspects of life. ”
Senior scientist Dr. Raman Gangakedkar He chaired and moderated the session. Other panelists, Dr. Plotkind, Dr. Krishna Ella, Chairman of Bharat Biotech, Dr. Gagandeep Kang, Professor of Christian Medical College in Vellore, and Dr. Umesh Shaligram, Director of the Indian Serum Institute (R & D) (SII), Talked about vaccine inequity and future directions around the world. The Pune International Center hosted the conference.
Looking back on his experience with an Indian vaccine manufacturer in the late 90’s, Dr. Protokin said: The vaccine I developed. ”
He states: “I was a little skeptical about what the end result would be. But a few years later, they (the Serum Institute) did an excellent job of making rubella vaccines in India, so just measles. I realized that I could immunize my child against rubella without measles. It is not necessary to say that the Serum Institute has become the world’s largest vaccine producer for many years. ”
SII launched a domestic rubella vaccine in India in 2000.
In praise of India’s vaccine efforts during the Covid pandemic, Dr. Protokin said: In addition, Indian doctors and scientists are influencing the world. ”
Dr. Plotkin said that all Covid vaccines used were manufactured on the basis of technology researched and developed over 20 years. “I think what we have learned is the importance of basic research before making vaccines. Second, vaccine companies can respond quickly and do typical Phase 1, Phase 2, and Phase 3 research. It can be done in a short period of time, and regulators can deal with and investigate the large amount of information generated during the vaccine development process. A large number of files with urgent notice. ”
All vaccine development efforts require the cooperation of government and public health authorities. “If the government doesn’t fully support the vaccine industry, problems will arise. Specifically, we don’t know exactly what the Indian government was doing,” he said.
“I don’t know what kind of support the Indian government is providing to science, but it is very important that the government supports basic science. The mRNA vaccine has been supported by the US government for 20 years. The result of these studies. The United States may be wealthier than other countries, but rather than spending money on the army, perhaps some of that money will ultimately benefit the population in scientific research. It should be used to help, “Dr. Protokin said.